1. Home
  2. RNAZ vs WNW Comparison

RNAZ vs WNW Comparison

Compare RNAZ & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • WNW
  • Stock Information
  • Founded
  • RNAZ 2016
  • WNW 2015
  • Country
  • RNAZ United States
  • WNW China
  • Employees
  • RNAZ N/A
  • WNW N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • RNAZ Health Care
  • WNW Consumer Discretionary
  • Exchange
  • RNAZ Nasdaq
  • WNW Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • WNW 5.7M
  • IPO Year
  • RNAZ 2021
  • WNW 2020
  • Fundamental
  • Price
  • RNAZ $11.51
  • WNW $1.73
  • Analyst Decision
  • RNAZ Strong Buy
  • WNW
  • Analyst Count
  • RNAZ 1
  • WNW 0
  • Target Price
  • RNAZ $280.00
  • WNW N/A
  • AVG Volume (30 Days)
  • RNAZ 251.6K
  • WNW 23.7K
  • Earning Date
  • RNAZ 08-22-2025
  • WNW 08-19-2025
  • Dividend Yield
  • RNAZ N/A
  • WNW N/A
  • EPS Growth
  • RNAZ N/A
  • WNW N/A
  • EPS
  • RNAZ N/A
  • WNW 9.06
  • Revenue
  • RNAZ N/A
  • WNW $158,485.00
  • Revenue This Year
  • RNAZ N/A
  • WNW N/A
  • Revenue Next Year
  • RNAZ N/A
  • WNW N/A
  • P/E Ratio
  • RNAZ N/A
  • WNW $0.19
  • Revenue Growth
  • RNAZ N/A
  • WNW N/A
  • 52 Week Low
  • RNAZ $6.15
  • WNW $0.95
  • 52 Week High
  • RNAZ $739.20
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 56.95
  • WNW 42.60
  • Support Level
  • RNAZ $10.16
  • WNW $1.65
  • Resistance Level
  • RNAZ $12.10
  • WNW $1.85
  • Average True Range (ATR)
  • RNAZ 1.40
  • WNW 0.09
  • MACD
  • RNAZ -0.11
  • WNW -0.01
  • Stochastic Oscillator
  • RNAZ 23.51
  • WNW 28.57

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: